Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.

Alfredo V Chua Jennifer Delmerico Haiyang Sheng Xin-Wei Huang Emily LiangLi YanShipra Gandhi Igor Puzanov Prantesh Jain Lori C SakodaGary R MorrowChristine B Ambrosone Charles S Kamen Song Yao

Published in: JCO oncology practice (2024)

Disparities in the representation and reporting of minoritized racial/ethnic groups persist in recent trials on ICIs, necessitating collaborative efforts for improved diversity and equitable cancer treatment access.

Keyphrases

clinical trial
adverse drug
quality improvement
african american
randomized controlled trial
emergency department
open label
electronic health record